IFN-γ treatment protocol for MHC-Ilo/PD-L1+ pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential

IFN-γ treatment protocol for MHC-Ilo/PD-L1+ pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential

Background Many cancer cells express a major histocompatibility complex class I low/ programmed cell death 1 ligand 1 positive (MHC-Ilo/PD-L1+) cell surface profile. For immunotherapy, there is, thus, an urgent need to restore presentation competence of cancer cells with defects in MHC-I processing/...

Full description

Bibliographic Details
Main Authors: Johann Gout, Thomas Seufferlein, Alexander Kleger, Katja Stifter, Jana Krieger, Leonie Ruths, Medhanie Mulaw, Andre Lechel, Martin Wagner, Reinhold Schirmbeck
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e000692.full

Internet

https://jitc.bmj.com/content/8/2/e000692.full

Similar Items